Gilead paused enrollment and terminated the trial due to safety concerns, following an FDA partial clinical hold on magrolimab studies in solid tumors. CD47 expression ... Patients with metastatic non ...

Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer.

A fascinating new study , published in the Journal of Clinical Investigation, has revealed an unexpected potential benefit of severe COVID infection ...

Advancements in thoracic surgery and robotic-assisted procedures enable cardiothoracic surgeons to improve the treatment of ...

This data supports the potential use of RTNova to target every metastatic site in multiple oncology indications including metastatic lung cancer. RTNova is uniquely ... By incorporating enveloped ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...

“We didn’t know if it was real ... tumors by 60% to 70% in mice with human cancers including breast, colon, lung, and melanoma. More studies are needed to confirm whether the cells have the ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Genprex (GNPX) announced it has entered into an exclusive license agreement with the University of Michigan, granting Genprex a worldwide, ...